SIGA Stock Analysis: Buy, Sell, or Hold?
SIGA - SIGA Technologies Inc.
$3.05
-0.07 (-2.24%)
▼
5d:
-6.73%
30d:
-12.86%
90d:
-35.52%
WAIT
LOW Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When SIGA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: SIGA shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: SIGA shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.77
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$4.82
36.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SIGA is currently trading at $3.05, which is considered oversold relative to its 30-day fair value range of $3.18 to $3.61. From a valuation perspective, the stock is trading at a discount (Forward PE: 3.0) compared to its historical average (3.8). Remarkably, the market is currently pricing in an annual earnings decline of 8.2% over the next few years. This pessimistic expectation contrasts with the company's recent 1802.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, SIGA is in a strong downtrend. The price is currently testing key support at $3.01. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (10th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $17.53 (+461.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SIGA is in a strong downtrend. The price is currently testing key support at $3.01. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (10th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $17.53 (+461.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.18 -
$3.61
Company Quality Score
50/100
(HOLD)
Options IV Signal
10th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
83.5%
Protect Your Profits
Holding SIGA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 10th percentile)
- NEUTRAL: Mixed technical signals (54/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 461.9% below Wall St target ($17.53)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.18 -
$3.61
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.58
(18.9%)
Support & Resistance Levels
Support Level
$3.01
Resistance Level
$3.43
Current Trend
Strong Downtrend
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.97
Wall Street Target
$17.53
(+461.9%)
Revenue Growth (YoY)
-11.3%
Earnings Growth (YoY)
1802.5%
Profit Margin
21.6%
Valuation Discount vs History
-8.2% cheaper
PE vs Historical
3.0 vs 3.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.2%
(market-implied from PE analysis)
1-Year Target
$2.86
(-8%)
2-Year Target
$2.63
(-16%)
3-Year Target
$2.41
(-23%)
3-Yr Target (if PE normalizes)
(PE: 3→4)
$3.09
(-1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 600.0%)
$71.69
(+2198%)
Base:
(SPY PE: 3.0, Growth: 600.0%)
$10.53
(+238%)
Bear:
(PE: 2.5, Growth: 600.0%)
$8.95
(+187%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (12x PE), but valuation improves significantly next year (3x PE) as earnings recover.
Trailing PE: 11.67 | Current EPS (TTM): $0.27
Bull Case
$6.93
(+127%)
Analyst growth 100.0%, PE expands to 12.8
Base Case
$6.30
(+107%)
Market implied 100.0%, PE stable at 11.7
Bear Case
$2.14
(-30%)
Severe decline -20.0%, PE contracts to 9.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 3.0 to 3.8
Stabilization Target:
$3.99
(+27.9%)
PE Expansion Potential:
+27.9%
Share & Embed Analysis
Last updated: August 10, 2026 4:53 AM ET
Data refreshes hourly during market hours. Next update: 5:53 AM
Data refreshes hourly during market hours. Next update: 5:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SIGA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$213 | 57 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$107 | 58 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$658 | 59 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 60 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$108 | 47 HOLD |
Advanced SIGA Option Strategies
Professional options setups generated by AI based on today's SIGA price and gamma walls.
